• <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
      <b id="1ykh9"><small id="1ykh9"></small></b>
    1. <b id="1ykh9"></b>

      1. <button id="1ykh9"></button>
        <video id="1ykh9"></video>
      2. west china medical publishers
        Keyword
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Keyword "不良事件" 62 results
        • Administration of Medical Adverse Event on Super Sized Hospital

          摘要:醫院有效事前監測、管控醫療不良事件,是保障患者安全、提高醫療質量的管理措施之一。超大型醫院對醫療不良事件管理的實戰中,建立、實施醫療安全隱患事件關鍵監測指標、醫療安全隱患事件篩查程序指標,積極開展醫療不良事件后臺監管工作,切斷醫療安全隱患事件向醫療風險事件演變、醫療風險事件向醫療糾紛事件演變的環節,保障患者安全。Abstract: Effective supervision in advance to the medical adverse event, is one of measures which hospital adopt to guarantee patient safety and enhance medical quality. The actual combat of supervision to the medical adverse event in super sized hospital, set up and put in practice on the key target of supervising the medical adverse event and the key target of ridding procedure, remain in the background and work actively on supervision on the medical adverse event, shut off the road from the medical safety issue to the medical risk issue and the road from the medical risk issue to the medical dissension in order to guarantee the patient safety.

          Release date:2016-09-08 10:12 Export PDF Favorites Scan
        • Development in immunotherapy of lung cancer

          Lung cancer is the leading cause of cancer-related deaths worldwide. Although improvement has been achieved in platinum-based chemotherapy and tyrosine kinase inhibitors-based molecular targeted therapy, they still have limitations. Immunotherapy has recently emerged as a very effective new treatment, and there is now growing enthusiasm in cancer immunotherapy worldwide. We summarized the effects of immune checkpoint inhibitors in clinical trials, and the current status and progress of anti programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) agents in lung cancer treatment. Attention has been paid to finding out the factors which influence the therapeutic effect of anti-PD-1/PD-L1 therapy and reducing the occurrence of adverse events.

          Release date:2022-11-22 02:01 Export PDF Favorites Scan
        • Predictive value of myocardial perfusion in the prognosis after coronary artery bypass grafting

          ObjectiveTo evaluate the value of myocardial perfusion change before and after coronary artery bypass grafting (CABG) in predicting postoperative major adverse cardiovascular events (MACE).MethodsA total of 70 CABG patients who received CABG completed by the same operator from January to November 2017 were selected, including 45 males and 25 females with an average age of 64.83±9.09 years. The patients were divided into two groups according to whether the patients had MACE after 1 year of the surgery, including a non-MACE group (group A, n=60) and a MACE group (group B, n=10). The clinical data of patients were compared.ResultsThere were statistical difference in the myocardial contrast echocardiography (MCE) score in the group A before and after surgery (P<0.05), and there were statistically significant differences in the left ventricular size and left ventricular ejection fraction (LVEF) value before and 1 year after surgery (P<0.001), but no statistically significant difference in the size of left atrium (P=0.075). There was no significant difference in the preoperative and postoperative MCE score, and preoperative and postoperative 1-year cardiac ultrasound score in the group B (P>0.05).ConclusionThe change of myocardial perfusion after CABG surgery is associated with postoperative MACE. The evaluation of myocardial perfusion before and after CABG surgery is of great significance for the prognosis evaluation of patients.

          Release date:2020-12-31 03:27 Export PDF Favorites Scan
        • Clinical risk factors for early adverse cardiovascular events after surgical correction of supravalvar aortic stenosis: A retrospective cohort study

          Objective To identify clinical risk factors for early major adverse cardiovascular events (MACEs) following surgical correction of supravalvar aortic stenosis (SVAS). Methods Patients who underwent SVAS surgical correction between 2002 and 2019 in Beijing and Yunnan Fuwai Cardiovascular Hospitals were included. The patients were divided into a MACEs group and a non-MACEs group based on whether MACEs concurring during postoperative hospitalization or within 30 days following surgical correction for SVAS. Their preoperative, intraoperative, and postoperative clinical data were collected for multivariate logistic regression. Results This study included 302 patients. There were 199 males and 103 females, with a median age of 63.0 (29.2, 131.2) months. The incidence of early postoperative MACEs was 7.0% (21/302). The multivariate logistic regression model identified independent risk factors for early postoperative MACEs, including ICU duration (OR=1.01, 95%CI 1.00-1.01, P=0.032), intraoperative cardiopulmonary bypass (CPB) time (OR=1.02, 95%CI 1.01-1.04, P=0.014), aortic annulus diameter (OR=0.65, 95%CI 0.43-0.97, P=0.035), aortic sinus inner diameter (OR=0.75, 95%CI 0.57-0.98, P=0.037), and diameter of the stenosis (OR=0.56, 95%CI 0.35-0.90, P=0.016). Conclusion The independent risk factors for early postoperative MACEs include ICU duration, intraoperative CPB time, aortic annulus diameter, aortic sinus inner diameter, and diameter of the stenosis. Early identification of high-risk populations for MACEs is beneficial for the development of clinical treatment strategies.

          Release date:2024-09-20 01:01 Export PDF Favorites Scan
        • 曲妥珠單抗生物類似藥與原研曲妥珠單抗聯合帕妥珠單抗治療HER2陽性乳腺癌患者療效與安全性的回顧性隊列研究

          目的比較HER2陽性乳腺癌患者在新輔助治療中原研曲妥珠單抗與生物類似藥的病理完全緩解(pathologic complete response,pCR)率及不良事件發生率的差異。方法采用回顧性分析法,收集 2021年1月至2022年10月期間在西南醫科大學附屬醫院乳腺外科完成TCbHP方案新輔助治療及手術治療的 117例人類表皮生長因子受體2(human epidermal growth factor receptor 2,HER2) 陽性乳腺癌患者的臨床病理資料。療效評價依據實體腫瘤療效評價標準(RECIST)1.1和 Miller-Payne(MP)系統,采用不良事件通用術語標準5.0進行不良事件發生率統計。結果117例患者中達到總體病理完全緩解(total pathologic complete response,tpCR)者曲妥珠單抗生物類似藥漢曲優(HLX02,Zercepac)組占比70.2% (33/47),原研曲妥珠單抗赫賽汀組占比72.9% (51/70),2組比較差異無統計學意義(P=0.755);達到乳腺病理完全緩解(breast pathologic complete response,bpCR)者漢曲優組占比76.6% (36/47),赫賽汀組占比74.3.9% (52/70),2組比較差異無統計學意義(P=0.777)。分子分型為HER2+HR+ (三陽性)組與HER2+HR–(HER2過表達)組患者的tpCR率比較差異有統計學意義(61.6%比88.6%,P=0.002),bpCR率比較差異也有統計學意義(67.1%比88.6%,P=0.009)。在HER2+HR+患者中漢曲優組與赫賽汀組的tpCR率比較差異無統計學意義(66.7%比57.5%,P=0.423),bpCR率比較差異也無統計學意義(75.8%比60.0%,P=0.154);在HER2+HR–患者中漢曲優組與赫賽汀組的的tpCR率比較差異無統計學意義(78.6%比93.3%,P=0.354),bpCR率比較差異也無統計學意義(78.6%比93.3%,P=0.354)。治療后所有患者均出現了可控的不良事件, 2組患者在心臟、血液系統和肝腎功能方面的不良事件發生率以及 ≥3 級不良事件的發生率均相似,差異均無統計學意義(P>0.05)。結論赫賽汀與其生物類似藥漢曲優在新輔助治療中的療效和安全性相似,這為 HER2 陽性乳腺癌患者提供了更多的治療選擇。

          Release date:2024-04-25 01:50 Export PDF Favorites Scan
        • Clinical value of Composite Congestion Score in predicting adverse events in patients with acute heart failure in emergency intensive care unit within 180 days

          Objective To explore the predictive value of Composite Congestion Score (CCS) in predicting adverse events within 180 days in patients with acute heart failure (AHF) in emergency intensive care unit (EICU). Methods The patients with AHF who were admitted to EICU of Zigong Fourth People’s Hospital between January 1, 2018 and December 31, 2020 were included consecutively. The patients were followed up for 180 days, and were divided into poor prognosis group and good prognosis group according to whether there were adverse events. Logistic regression equation was used to screen independent risk factors for predicting adverse events in patients with AHF within 180 days after leaving EICU. To compare the discrimination, calibration and clinical usefulness of independent risk factors at EICU discharge and the Acute Physiology and Chronic Health Assessment SystemⅡ (APACHEⅡ) score at EICU admission to predict the occurrence of adverse events of AHF. Results A total of 71 patients were included, including 32 patients with good prognosis and 39 patients with poor prognosis. Except for age, APACHEⅡscore at EICU admission and CCS score at EICU discharge (P<0.05), there was no significant difference in other indicators between the two groups (P>0.05). Logistic regression analysis showed that CCS score at EICU discharge [odds ratio (OR)=2.806, 95% confidence interval (CI) (1.428, 5.512), P=0.003], age [OR=1.086, 95%CI (1.017, 1.159), P=0.013] were independent risk factors for predicting death or returning to hospital within 180 days. Among them, the CCS score at EICU discharge combining with age had a positive improvement ability compared with the CCS score at EICU discharge, the age, and the APACHE Ⅱ score at EICU admission. The calibration curves of the four scoring methods for predicting adverse events within 180 days showed that the CCS score at EICU discharge had the highest calibration and the calibration of age was the lowest. The decision curve showed that the clinical usefulness of age, the CCS score at EICU discharge and the CCS score at EICU discharge combining with age was better than the APACHE Ⅱ score at EICU admission. Conclusions The CCS score of patients with AHF at EICU discharge is closely related to adverse events within 180 days. The CCS score is designed based on clinical variables, simple and practical. The combination of age and the CCS score at EICU discharge will further enhance its clinical application value.

          Release date:2023-01-16 09:48 Export PDF Favorites Scan
        • 護理風險預防對老年患者行經皮冠狀動脈介入治療不良事件發生率的影響

          目的 討論風險預防為主導的護理服務對老年患者行經皮冠狀動脈介入治療(PCI)護理不良事件發生率的影響。 方法 2009年1月-12月,對82例行PCI的老年患者(對照組)采用規范化的常規護理;2010年1月-12月期間,針對該護理中易出現的不良事件,在進一步改進護理服務措施基礎上強化風險控制與預防,使88例后期行該術的患者(試驗組)其護理不良事件得到有效控制。 結果 試驗組發生不良事件幾率明顯低于對照組,差異有統計學意義(P<0.05)。 結論 加大老年患者行PCI的護理風險防范,改進和完善護理服務方式,可有效減少PCI術后護理不良事件的發生。

          Release date:2016-09-08 09:16 Export PDF Favorites Scan
        • Analysis of risk factors for the prediction of short-term adverse event associated with acute non-high-risk pulmonary embolism

          Objective To evaluate the prognostic value of several indexes of laboratory and ultrasonic cardiogram for adverse events in 3 months following the diagnosis of acute non-high-risk pulmonary embolism. Methods A total of 266 cases of acute non-high-risk pulmonary embolism patients diagnosed and treated in Beijing Anzhen Hospital during 2016 to 2017 were retrospectively analyzed. The patients were divided into a bad event group and a control group according to whether there was a bad event happened in 3 months following the diagnosis. The general data, indexes of laboratory and ultrasonic cardiogram were compared. Univariate and multivariate COX regression analysis were conducted to explore independent risk factors for 3 months’ poor prognosis. Results The bad outcome group had a significantly higher value of the proportion of suffering from connective disease and active cancer, C-reaction protein, monocyte/lymphocyte ratio (MLR) and urea while a significantly lower level of red blood cell count and hemoglobin compared with the control group (all P<0.05). Univariate and multivariate COX regression analysis showed that both the MLR (hazard ratio 14.59, 95% confidence interval 1.48 - 143.69, P=0.02) and suffering from connective disease (hazard ratio 5.85, 95% confidence interval 1.11 - 30.81, P=0.04) remain significantly different between the bad events group and the control group. Conclusion MLR at the admission may be related to the 3 months death of acute non-high-risk pulmonary embolism.

          Release date:2022-04-22 10:34 Export PDF Favorites Scan
        • Effectiveness and safety of multi-artery graft strategy for coronary bypass with small incision in the left chest for 64 patients

          ObjectiveTo investigate the safety and effectiveness of the multi-artery graf tstrategy for coronary bypass (MICS-CABG) with small incision in the left chest, and to provide experience for the promotion of this technique.MethodsThe clinical data of 64 patients with MICS-CABG in Department of Cardiac Surgery of Peking University Third Hospital from December 2015 to November 2019 were retrospectively analyzed. There were 54 males and 10 females, aged 36-77 (61.1±8.7) years. The left lateral thoracic incision (5-8 cm) was made through the 5th intercostal incision, and the operation was performed under off-pump CABG. With the help of the chest wall suspension device and the heart fixator, the proximal anastomosis of the ascending aorta, anastomosis of the target vessels of the ?left anterior descending (LAD), left circumflex (LCX) and right coronary artery (RCA) systems were completed. The number of grafts was 2-4 (2.3±0.5) including 2 grafts in 45 patients, 3 grafts in 17 patients and 4 grafts in 2 patients. Three patients were treated with percutaneous intervention (PCI) hybridization and 62 patients were treated with total artery bypass graft. Coronary angiography was performed within 7 days after the operation to evaluate the graft patency rate. The incidence of major adverse cardiac and cerebrovascular events (MACCE) was recorded in the follow-up. The MACCE rate was calculated by Kaplan-Meier method.ResultsNone of the patients was transferred to thoracotomy and no intra-aortic balloon counterpulsation (IABP) or extracorporeal membrane oxygenation (ECMO) was used during the operation. Incision infection was in 1 patient and reoperation in 2 patients (all were postoperative hemorrhage). Within 30 days after surgery, MACCE occurred in 1 patient, including 1 patient of non-fatal myocardial infarction. The overall patency rate of angiography bypass was 96.2%, and the patency rate of anterior descending branch bypass was 98.2%. Follow-up was performed from 12 to 60 months (median follow-up time was 28 months). The loss rate was 7.8% (5/64). The incidence of MACCE was 84.9% (95%CI 79.5%-90.3%).ConclusionThe MICS-CABG can achieve completed re-vascularization and totally artery-CABG and the short-term and medium-term clinical results of the operation are good.

          Release date:2021-03-05 06:30 Export PDF Favorites Scan
        • Safety of hand disinfectants: a systematic review

          ObjectiveTo systematically review the safety of hand disinfectants. MethodsPubMed, EMbase, The Cochrane Library, INAHTA, WanFang Data, CNKI and VIP databases were electronically searched to collect studies on the safety of hand disinfectants from inception to February 1st, 2021. Two reviewers independently screened the literature, extracted data and assessed the risk of bias of the included studies; then, a systematic review was conducted. ResultsA total of 50 studies were included. The reported adverse events were eye and nasal mucosal irritation, hand adverse events with skin itching, rash, erythema, edema and so on. A total of 29 brands such as 3M Avagard and 26 ingredients such as ethanol were reported to be related to the above adverse events. Hand disinfectants containing glycerin, silicone oil, vitamin B, plant extracts and other emollients could reduce the incidence of adverse events. ConclusionCurrent evidence shows that hand disinfectants containing emollients and free from ethanol, chlorhexidine and other ingredients are related to fewer adverse events. Due to the limited quality and quantity of the included studies, more high-quality studies are needed to verify the above conclusion.

          Release date:2022-07-14 01:12 Export PDF Favorites Scan
        7 pages Previous 1 2 3 ... 7 Next

        Format

        Content

      3. <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
          <b id="1ykh9"><small id="1ykh9"></small></b>
        1. <b id="1ykh9"></b>

          1. <button id="1ykh9"></button>
            <video id="1ykh9"></video>
          2. 射丝袜